REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Esmart Drug Mindoro Corp. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Esmart Drug Mindoro Corp. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Esmart Drug Mindoro Corp. is an enterprise in Philippines, with the main office in San Jose. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 26, 1990. In its most recent financial highlights, the company reported a net sales revenue drop of 19.71% in 2024. There was a total negative growth of 17.81% in Esmart Drug Mindoro Corp.’s total assets over the same period.

Headquarters
Liboro Cor. Sikatuna St. Occidental Mindoro
San Jose;

Contact Details: Purchase the Esmart Drug Mindoro Corp. report to view the information.

Basic Information
Financial Auditors:
Purchase the Esmart Drug Mindoro Corp. report to view the information.
Incorporation Date:
April 26, 1990
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Treasurer
Ownership Details
Purchase this report to view the information.
31.39%
Purchase this report to view the information.
31.34%
Purchase this report to view the information.
31.1%
Purchase this report to view the information.
6.16%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Esmart Drug Mindoro Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-19.71%▼
Total operating revenue
-19.71%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
-17.81%▼
Total Equity
-11.2%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
7.95%▲
Cash Ratio
0.7%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo